BCL2 and diffuse large B-cell lymphoma: Hi-C analysis revealing MYC amplification concurrent with an IGH::BCL2 fusion supported a diagnosis of DLBCL, distinct from HGBCL with concurrent MYC and BCL2 rearrangements.